Abstract
Background and Hypothesis
Functional deficits during adolescence have proved to be important risk factors for later psychosis at 2 to 3-year follow-up. The aim of the current study was to evaluate whether social and role functioning in clinical high-risk (CHR) youth is associated with transition to psychosis.
Study Design
Data from the North American Prodrome Longitudinal Studies (NAPLS 2, NAPLS 3) were combined with outcome data from the NAPLS Long-Term Follow-up study to assess the relationship between baseline social and role functioning and later transition to psychosis. Participants included 1474 CHR individuals from NAPLS 2 (n = 764) and NAPLS 3 (n = 710), of whom 198 (13%) are known to have transitioned to psychosis.
Study Results
Individuals who later transitioned to psychosis had more severe positive and negative symptoms and poorer social and role functioning at baseline compared to those who did not. Higher baseline social and role functioning was significantly associated with a reduced hazard of transition (HR = 0.864, P = .0013; HR = 0.898, P = .0004, respectively), whereas a decline in social and in role functioning was significantly associated with an increased hazard of transition (HR = 1.229, P = .0013; HR = 1.124, P = .002, respectively).
Conclusions
These results underscore the significance of social and role functioning in predicting subsequent transition to psychosis in CHR participants, suggesting an underlying vulnerability that is possibly independent of clinical symptoms. Early intervention that includes a focus on social and role functioning in high-risk youth may reduce the risk of future functional disability and perhaps a later psychotic episode.
Keywords: clinical high-risk, ultra-high-risk, social functioning, global functioning: Social, global functioning: Role, transition to psychosis
Introduction
Poor social functioning is a key feature of schizophrenia and often proves more persistent and disabling than its positive symptoms.1,2 Although functional disability is commonly linked with chronic schizophrenia, evidence has shown that these impairments emerge early in the disease.3,4 In fact, functional disability, especially poor social functioning, is prevalent among individuals at clinical high-risk (CHR) for psychosis.5 To acknowledge the important work of Dr. Barbara Cornblatt in this domain of early functional disability, this paper aims to examine social and role functioning within the North American Prodrome Longitudinal Study (NAPLS) consortium.
Funded by the National Institute for Mental Health (NIMH), the NAPLS consortium began in 2004 under the leadership of Dr. Robert Heinssen. The original members Addington, Cadenhead, Cannon, Cornblatt, McGlashan, Perkins, Seidman, Tsuang, Walker, and Woods, representing eight sites, had independently conceived ongoing and/or completed studies with CHR youth. The objective was to retrospectively integrate these projects, and aggregate the descriptive, clinical, and functioning variables into a federated longitudinal database to address certain scientific questions that would later lead to new collaborative large-scale projects exploring the development of psychosis.6
NAPLS 2 was the first prospective longitudinal study collecting data from all eight sites with a 2-year follow up.7 NAPLS 3 followed as the second prospective longitudinal study building on NAPLS 2, adding investigators Bearden (University of California at Los Angeles [UCLA]) and Mathalon with UCSF as the 9th site.8 In 2021, the consortium was funded by NIMH for a longitudinal study, “Predictors and Moderators of Long-Term Outcome of Persons at Clinical High Risk for Psychosis (LTF).” The LTF project aims to locate participants from NAPLS 1-3 and affiliated studies from the NAPLS sites, 5-20 years after the initial involvement of CHR participants.9
Since NAPLS 1 data came from various projects, some variables were recoded to fit a standard measure.6 The assessment of functioning was inconsistent, ranging from lengthy interviews to self-reports to brief clinician-rated scales. Designed for individuals with schizophrenia, functioning measures then in use were not suitable for the CHR population, which includes younger individuals with varying levels of functioning. Thus, 2 new functional measures were created for NAPLS 1 to assess CHR individuals aged 12-25.10 These measures, Global Functioning: Social (GF:Social)11 and Global Functioning: Role (GF:Role)12 aimed to evaluate subtle levels of CHR functional difficulties with detailed anchors. Each scale is brief, easy to use, and provides a clinician rated single overall score similar to the Global Assessment of Functioning,13,14 but focusing separately on social and role functioning without being confounded with psychiatric symptoms. Complete development and testing details are available in Cornblatt et al.,10 with a subsequent validation paper.15 Further details on the scales are presented in the Methods section below.
In addition to being the main functional measures in NAPLS 1-3, the GF:Social and Role are the most commonly used functioning measures in CHR research and are included in the NIMH-supported PhenX Early Psychosis Clinical Services Toolkit.16 They have been employed in multiple studies, demonstrating that CHR youth have significantly poorer functioning than age-matched healthy controls.15,17-19 Notably, social functioning tends to remain poor over time with little improvement observed, even when there is an improvement in attenuated psychotic symptoms (APS).18 Social and role functioning has also been examined in relation to the transition to psychosis. In NAPLS 1, CHR individuals who developed psychosis exhibited significantly poorer social functioning than those who did not.20 Furthermore, in NAPLS 1, it was shown that CHR participants who transitioned to psychosis were significantly more socially impaired compared to those who did not. This was not the case for role functioning, which, although impaired, was not associated with later transition to psychosis.5
A second NAPLS 2 paper by Carrión and colleagues21 reported that pre-baseline social decline was a predictor of poorer functional outcomes, as well as transition to psychosis. However, role functioning did not show the same predictor potential; instead it appeared to be more of an illness indicator that worsened over time.21 The next step in CHR research involved developing predictive models.22 The NAPLS group created an individualized risk calculator and pre-baseline decline in social functioning was a key variable in the model.23 External validation of the NAPLS calculator24 supported decline in social functioning as an important component of the model. In summary, the GF: Social and Role have been consistently utilized, highlighting the significance of social functioning in the outcome of CHR individuals.
The key aim of this article is to examine the association between functioning, as assessed by the GF: Social and Role, and transition to psychosis.
Methods
Participants
Participants for this paper were a pooled sample of 1474 CHR individuals from NAPLS 2 (n = 764) and NAPLS 3 (n = 710). NAPLS 2 and 3 were multisite longitudinal studies conducted at Emory University, Harvard University, University of North Carolina, Chapel Hill, Yale University, Zucker Hillside Hospital, University of Calgary, and University of California at Los Angeles (UCLA), at San Diego, and at San Francisco. Detailed information on recruitment and methods of NAPLS 2 and 3 is described in prior publications.7,8
The inclusion criteria for NAPLS 2 and 3 required participants to be between 12 and 30 years old and to meet the Criteria of Psychosis-Risk Syndromes (COPS) based on the Structured Interview for Psychosis-Risk Syndromes (SIPS).25 Exclusion criteria included meeting criteria for current or lifetime Axis I psychotic disorder, an IQ <70, or a history of a central nervous system disorder. Non-psychotic DSM-IV and -5 disorders were not exclusions provided they did not account for APS.
Centralized IRB approval was obtained to find, recontact and interview past CHR participants using a variety of methods for the NAPLS LTF study.9
Each site conducted extensive searches to find participants. To date, 452 participants from NAPLS 2 (n = 199) and NAPLS 3 (n = 253) have consented to follow-up and have been interviewed. In NAPLS 2 and 3 there were originally 166 CHR participants who transitioned to psychosis (95 from NAPLS 2, 71 from NAPLS 3). In the LTF study to date, 74 individuals who made the transition to psychosis have been interviewed. These include 42 of the original 166 individuals who transitioned in NAPLS 2 and 3 and another 32 individuals. Of those 32, 23 had transitioned after NAPLS 2 and 3 had ended, and 9 had transitioned to psychosis within the 2-year follow-up framework of NAPLS 2 and 3 but had dropped out prior to the time of transition. Therefore, the total transition rate of those we interviewed is 16% for the combined NAPLS 2 and 3 sample using LTF data.
Study Measures
The Structured Clinical Interview for DSM-IV and for DSM-5 was used to rule out psychotic diagnoses at entry to NAPLS 2 and 3, and to confirm psychotic diagnoses for those who made a transition to psychosis.26,27 The SIPS was used to confirm NAPLS 2 and 3 participants met COPS criteria,25 and in NAPLS 2, 3,f and LTF, the Scale of Psychosis-Risk Symptoms (SOPS) was used to assess APS and negative symptoms.25 Details of the 5 positive and 6 negative symptoms of the SOPS are presented in Supplementary material.
Functioning was assessed using the GF:Social and Role scales.10 The GF:Social scale focuses on social functioning, including family relationships, with an emphasis on relationships and interactions with peers. The GF:Role scale evaluates school and work performance. Both are rated on a 10-point scale (10 = superior functioning, 1 = extreme dysfunction). Training and certification for these scales include a training video, manual, and reliability vignettes. Rater certification requires meeting reliability criteria, including alignment with gold standard scores and interclass correlations above 0.80 on vignette scores. The scales have been used in numerous CHR and early psychosis studies and have excellent interrater reliability and strong discriminant and convergent validity.10,15 The GF scales have been translated into 8 languages demonstrating their international utility and applicability in CHR research—German, French, Italian, Spanish, Chinese, Korean, Japanese, and Danish—and have been included in the multisite international AMP-SCZ project.28 The psychometric properties of the French and Italian versions have been published, demonstrating excellent interrater reliability and good to excellent concurrent validity.29,30 In the United States, the GF scales are included in the Core Assessment Battery of the Early Psychosis Intervention Network (EPINET)31 and are used to monitor treatment outcomes of several thousand young people enrolled in Coordinated Specialty Care programs for first episode psychosis.32
Procedures
Baseline measures for all NAPLS 2 and 3 participants were available from our databases. The data used in this paper included demographics, SOPS positive and negative symptoms, and GF: Social and Role. For participants in NAPLS 2 and 3 who transitioned to psychosis within 2 years of each study, the time from baseline to transition was documented.
Recruitment for participants for the LTF study utilized a methodical approach, targeting individuals who had previously consented to be contacted for future studies at the time of their initial participation. Multiple strategies were employed to establish contact with eligible participants. Research staff identified past participants who had explicitly indicated their preference not to be recontacted at the time of initial participation; these individuals were excluded from further outreach.9
Participants who had agreed to be re-contacted were approached via telephone and/or email, followed by letters or calls to other specified contacts. For all other past participants, that is those from whom permission to re-contact had not been sought at the end of NAPLS 2 and 3, letters were first sent. If there was no reply, research staff would call the participant, or anyone listed as an alternative contact. Upon establishing communication, the follow-up study would be explained. If appropriate, official sources such as hospital records, Department of Motor Vehicles (DMV), social security administration, and marriage and divorce records were consulted to obtain contact information for participants. As a final measure, social media and internet searches were conducted. Information regarding past participants was also gathered through relatives, as well as death and incarceration records. More specific details of the methods of the NAPLS LTF can be found in Cadenhead et al.9
LTF interviews were mostly conducted via secure teleconferencing due to the pandemic at the time the study started. Data collected at those interviews that were used for this article included the SIPS, to determine if the participant still met criteria for CHR or the criteria for conversion to psychosis had been met, the SOPS, to measure current positive and negative symptoms, and the GF: Social and GF: Role scales. All of these procedures and methods were approved by the Centralized IRB.
Statistical Analyses
Descriptive analyses to demonstrate differences between participants who transitioned to psychosis and those who did not, as well as baseline differences between participants who were interviewed and those who were not, were assessed using independent samples t-tests for continuous variables and chi-square tests for categorical variables.
Kaplan–Meier survival analysis was conducted to estimate the probability of remaining transition to psychosis-free over time (in days). Additionally, Cox proportional hazards models were used to examine the association between baseline Global Functioning: Social and Role scores and decline in Global: Social and Role with time to transition. These analyses were performed for the combined NAPLS 2 and 3 sample including all known transitions, that is including those observed in the LTF assessments. Due to the high likelihood of non-random missingness these analyses were then repeated with the transitions that were observed during the time frame of the original NAPLS 2 and 3 excluding the LTF participants.
All statistical analyses were conducted using the IBM Statistical Package for the Social Sciences (SPSS) version 25 and Statistical Analysis Software (SAS) version 9.4.
Results
Demographics
Table 1 presents demographics for the NAPLS 2 and 3 sample at baseline and for the LTF sample at the time of their interview.
Table 1.
Demographics of NAPLS 2 and 3 and Long-Term Follow-up Participants
|
NAPLS 2 and 3 n = 1474 At baseline |
LTF n = 452 At interview |
|
|---|---|---|
| Mean (SD) | Mean (SD) | |
| Age | 18.35 (4.14) | 27.48 (5.37) |
| Years of education | 11.36 (2.94) | 14.80 (2.44) |
| Frequency (%) | Frequency (%) | |
| Sex | ||
| Male | 821 (55.7) | 213 (47.1) |
| Female | 653 (44.3) | 239 (52.9) |
| Racial a | ||
| Indigenous Groups | 27 (1.8) | 4 (0.9) |
| East Asian | 61 (4.1) | 16 (3.6) |
| Southeast Asian | 26 (1.8) | 5 (1.1) |
| South Asian | 42 (2.8) | 11 (2.4) |
| Black | 200 (13.6) | 62 (13.9) |
| Central/South American | 75 (5.1) | 28 (6.2) |
| West/Central Asian & Middle Eastern | 14 (0.9) | 2 (0.4) |
| White | 829 (56.2) | 263 (58.2) |
| Native Hawaiian or Pacific Islander | 5 (0.3) | 2 (0.4) |
| Multiracial | 192 (13.0) | 58 (12.9) |
| Maximum education achievedb | ||
| Some grade school | 776 (52.6) | 21 (4.7) |
| High school | 549 (37.2) | 195 (43.3) |
| Post-secondary education | 133 (9.0) | 181 (40.2) |
| Postgraduate | 10 (0.7) | 53 (11.8) |
LTF—NAPLS 2 and 3 participants in the long-term follow-up study.
East Asian includes: Chinese, Japanese, Korean; Southeast Asian includes: Cambodian, Indonesian, Vietnamese; South Asian includes: Indian, Pakistani, Sri Lankan; West/Central Asian and Middle Eastern includes: Egyptian, Lebanese, United Arab Emiratis, Afghan, Iranian.
Grade school includes: completion up to some grade school but not high school. Post-secondary education includes: College, Technical school, and University. Postgraduate includes: Graduate school and Professional school.
Differences Between Those in the LTF Study and Those Not Yet Found or Interviewed
Those who have been found to date and interviewed were compared to those who have not yet been found or interviewed across several key variables. A significantly higher proportion of females have been located and interviewed compared to males (χ = 18.44, P < .0001). Of the 821 males, 214 (26.1%) were interviewed, and of the 653 females, 238 (36.4%) were interviewed. There were no significant racial differences (χ = 9.76, P = .371) between those interviewed and those not. Comparisons on age, years of education, positive and negative symptoms, and social and role functioning at baseline are presented in Table 2. The only significant differences observed were that those who had been interviewed had significantly better ideational richness and less grandiosity. Those interviewed had higher ratings on current social and role functioning, and on the lowest social functioning in past year and highest role functioning in the past year. There was no difference in social decline.
Table 2.
Baseline Differences Between Participants Who Were Interviewed and Those Not Interviewed
|
Interviewed n = 452 |
Not interviewed n = 1022 |
Test statistic | Significance value | Effect size | |
|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | t | P | Cohens d | |
| Age | 18.28 (4.09) | 18.38 (4.16) | 0.42 | .674 | 0.024 |
| Years of education | 11.34 (2.93) | 11.36 (2.94) | 0.08 | .937 | 0.005 |
| Total SOPS positive | 12.26 (3.74) | 12.47 (3.62) | 1.0 | .319 | 0.056 |
| Unusual Thought Content | 3.55 (1.22) | 3.53 (1.24) | −0.38 | .702 | −0.022 |
| Suspiciousness | 2.83 (1.49) | 2.96 (1.47) | 1.64 | .100 | 0.093 |
| Grandiose Ideas | 0.86 (1.26) | 1.01 (1.34) | 2.01 | .044 | 0.114 |
| Perceptual Abnormalities | 3.20 (1.40) | 3.06 (1.47) | −1.74 | .082 | −0.098 |
| Disorganized Communication | 1.83 (1.52) | 1.91 (1.46) | 0.96 | .339 | 0.054 |
| Total SOPS negative | 11.58 (6.15) | 12.18 (6.22) | 1.7 | .089 | 0.097 |
| Social Anhedonia | 2.26 (1.67) | 2.38 (1.73) | 1.26 | .209 | 0.071 |
| Avolition | 2.45 (1.61) | 2.53 (1.63) | 0.9 | .367 | 0.051 |
| Decreased Expression of Emotion | 1.29 (1.41) | 1.42 (1.49) | 1.49 | .135 | 0.085 |
| Decreased Experience of Emotions and Self | 1.87 (1.66) | 1.87 (1.65) | −0.02 | .981 | −0.001 |
| Decreased Ideational Richness | 1.06 (1.24) | 1.24 (1.33) | 2.39 | .017 | 0.136 |
| Occupational Functioning | 2.64 (2.03) | 2.74 (1.97) | 0.84 | .401 | 0.048 |
| GF: Social | |||||
| Current | 6.43 (1.54) | 6.24 (1.55) | −2.24 | .025 | −0.127 |
| Lowest in past year | 6.11 (1.48) | 5.91 (1.57) | −2.3 | .022 | −0.130 |
| Highest in past year | 7.07 (1.41) | 6.95 (1.47) | −1.49 | .135 | −0.085 |
| Decline in social functioning | 0.64 (0.91) | 0.72 (0.98) | 1.35 | .177 | 0.076 |
| GF: Role | |||||
| Current | 6.27 (2.23) | 5.99 (2.16) | −2.22 | .027 | −0.126 |
| Lowest in past year | 5.79 (2.26) | 5.58 (2.18) | −1.7 | .089 | −0.096 |
| Highest in past year | 7.50 (1.54) | 7.21 (1.74) | −3.25 | .0012 | −0.176 |
| Decline in role functioning | 1.24(1.71) | 1.21(1.59) | −0.23 | .819 | −0.013 |
Abbreviations: GF: Role = Global Functioning: Role; GF: Social = Global Functioning: Social; SOPS = Scale of Psychosis-Risk Symptoms.
Differences Between Participants Who Transitioned to Psychosis and Those Who Did Not
The transition group consisted of any individual who had transitioned to psychosis either within the original NAPLS 2 and 3 projects or whose transition had been recorded through the LTF study. Differences between these 2 groups for age, education, race, SOPS symptoms, and social and role functioning are presented in Table 3. Significant differences, indicating more severe symptoms at baseline, for those who later transitioned to psychosis were observed for all positive symptoms except grandiose ideas and perceptual abnormalities, and for all negative symptoms except avolition and decreased experience of emotions and self. Those who transitioned had poorer social and role functioning, both currently and for the lowest score in the past year, and an increased decline in social functioning in the year prior to baseline.
Table 3.
Baseline Differences Between Those Who Transitioned to Psychosis and Those Who Did Not
|
Transitioning group n = 198 |
Non-transitioning n = 1276 |
Test statistic | Significance value | Effect size | |
|---|---|---|---|---|---|
| Mean (SD) | Mean (SD) | t | P | Cohens d | |
| Age | 18.35 (3.88) | 18.35 (4.19) | 0.0 | 1.0 | 0.000 |
| Years of education | 11.26 (2.73) | 11.37 (2.97) | 0.47 | .635 | 0.036 |
| Total SOPS Positive | 13.57 (3.84) | 12.22 (3.60) | −4.83 | <.0001 | −0.37 |
| Unusual Thought Content | 3.98 (1.27) | 3.46 (1.21) | −5.57 | <.0001 | −0.426 |
| Suspiciousness | 3.19 (1.51) | 2.88 (1.47) | −2.76 | .006 | −0.211 |
| Grandiose Ideas | 1.04 (1.40) | 0.95 (1.30) | −0.92 | .356 | −0.071 |
| Perceptual Abnormalities | 3.13 (1.59) | 3.10 (1.43) | −0.23 | .819 | −0.019 |
| Disorganized Communication | 2.24 (1.64) | 1.83 (1.45) | −3.28 | .001 | −0.274 |
| Total SOPS Negative | 13.30 (6.51) | 11.78 (6.13) | −3.19 | .002 | −0.245 |
| Social Anhedonia | 2.66 (1.74) | 2.29 (1.70) | −2.84 | .005 | −0.217 |
| Avolition | 2.70 (1.65) | 2.48 (1.62) | −1.65 | .099 | −0.126 |
| Decreased Expression of Emotion | 1.62 (1.59) | 1.34 (1.45) | −2.48 | .013 | −0.190 |
| Decreased Experience of Emotions and Self | 1.85 (1.69) | 1.87 (1.65) | 0.17 | .866 | 0.013 |
| Decreased Ideational Richness | 1.48 (1.42) | 1.14 (1.28) | −3.19 | .002 | −0.264 |
| Occupational Functioning | 3.03 (2.07) | 2.66 (1.97) | −2.42 | .016 | −0.186 |
| GF: Social | |||||
| Current | 5.98 (1.56) | 6.35 (1.54) | 3.05 | .002 | 0.233 |
| Lowest in past year | 5.70 (1.54) | 6.01 (1.54) | 2.63 | .009 | 0.201 |
| Highest in past year | 6.84 (1.45) | 7.01 (1.45) | 1.53 | .126 | 0.117 |
| Decline from highest to current | 0.86 (1.04) | 0.67 (0.95) | −2.6 | .009 | −0.199 |
| GF: Role | |||||
| Current | 5.65 (2.17) | 6.15 (2.18) | 2.97 | .003 | 0.227 |
| Lowest in past year | 5.27 (2.19) | 5.70 (2.20) | 2.58 | .01 | 0.197 |
| Highest in past year | 7.14 (1.75) | 7.32 (1.67) | 1.46 | .144 | 0.112 |
Abbreviations: GF: Role = Global Functioning: Role; GF: Social = Global Functioning: Social; SOPS = Scale of Psychosis-Risk Symptoms.
Survival Analysis
In Figure 1, for all known transitions, the Kaplan–Meier Survival Curve illustrates the cumulative probability of experiencing all known transitions over time, up to approximately 5000 days. The curve shows that the cumulative probability of transition increased rapidly during the early phase of follow-up and plateaued thereafter. By approximately 4000 days, the cumulative probability of transition approached 1.0, indicating that near all those who transitioned to psychosis had transitioned by that time.
Figure 1.
Kaplan–Meier Survival Curve (NAPLS 2 and 3, All Known Transitions Over Full Follow-up) for Transition Group.
In the combined NAPLS 2 and 3 sample using all known transitions, higher baseline GF: Social scores were significantly associated with a lower hazard of transition (HR = 0.864, 95% CI, 0.79-0.944, P = .0013), corresponding to a 13.6% lower hazard per one-unit increase in GF: Social. Conversely, decline in GF: Social was significantly associated with an increased hazard of transition (HR = 1.229, 95% CI, 1.084-1.393, P = .0013), indicating that each one-unit increase in decline was associated with a 22.9% higher hazard of transition.
Similarly, higher baseline GF: Role scores were significantly associated with a lower hazard of transition (HR = 0.898, 95% CI, 0.846-0.953, P = .0004), corresponding to an 18.6% lower hazard per one-unit increase. Decline in GF: Role was significantly associated with an increased hazard (HR = 1.124, 95% CI, 1.044-1.210, P = .002), with each one-unit increase in decline associated with a 12.4% higher hazard of transition.
To address the possibility of non-random missingness these analyses were re-run excluding the LTF participants. The results were as follows.
Higher baseline GF: Social scores were significantly associated with a lower hazard of transition (HR = 0.809, P = .0002), corresponding to a 19.1% lower hazard per one-unit increase in GF: Social. Decline in GF: Social was significantly associated with an increased hazard of transition (HR = 1.29, P = .0012); each one-unit increase in decline was associated with a 29% increased hazard of transition.
Similarly higher baseline GF: Role scores remained significantly associated with a lower hazard of transition (HR = 0.89, P = .003), corresponding to an 10.8% lower hazard per one-unit increase. GF: Role decline was significantly associated with an increased hazard of transition (HR = 1.14, P = .007), with each one-unit increase in decline associated with a 14.3% higher hazard of transition.
Discussion
This article examines the association of baseline social and role functioning and later transition to psychosis in 3 projects within the NAPLS consortium: NAPLS 2, NAPLS 3, and the LTF study. For the first time, social and role functioning has been assessed using the combined NAPLS 2 and 3 studies. Comparison between individuals who transitioned to psychosis with those who did not, revealed significant differences in both baseline positive and negative symptoms, as well as in current social and current role functioning.
Most transitions in NAPLS 2 and 3 occurred within the first year, with a steady decline over the 2-years of the study period. However, longer-term follow-up in the LTF study revealed that this decline continued to occur beyond 2 years, suggesting that even though transitions mostly occur earlier, there are individuals whose transition can occur many years after the initial assessment.
When considering transition to psychosis, regardless of whether they occurred within 2 years or later, social and role functioning as measured by the GF: Social and the GF: Role were both significantly associated with transition to psychosis. Moreover, a decline in both social and role functioning in the year prior to ascertainment were significantly related to later transition. The findings with respect to social functioning are consistent with previous research including the work of Dr. Cornblatt.5,20,21,23,33-36 For example, in a small sample in an early publication5 Cornblatt and colleagues first reported that even when controlling for neurocognition, those who develop psychosis had significantly poorer functioning than those who did not. This was later supported in the full NAPLS 2 sample.21 Furthermore, in this paper Carrion, Cornblatt and colleagues reported that amongst those who transitioned to psychosis, participants who had demonstrated a decline in functioning in the year prior to baseline had the poorest functioning at 12 months or post transition.21
In this current study, although social functioning has consistently been the stronger and more independent predictor when both NAPLS 2 and 3 samples were combined into a much larger sample, both role functioning and a decline in role functioning were significantly associated with later transition to psychosis. As noted earlier,17 although close, the GF: Role measure did not always demonstrate the same predictive value as social functioning. It is possible that role functioning may be more strongly influenced by environmental factors—such as changing schools, job loss, or low employment rates—than social functioning.1 Cornblatt and colleagues suggested that role functioning is particularly responsive to these conditions and may represent a state factor linked to poor long-term functional outcome.37 Thus, it is not surprising that role in addition to social functioning is associated with transition especially as they can interact, influencing each other over time.
Dr. Cornblatt introduced the neurodevelopmental RAP model, which links early decline in social functioning during adolescence to a biological vulnerability influenced by genetics and behavior, reflecting underlying brain pathology.38 This model implies that abnormalities beyond APS may predict future psychosis.37 Cornblatt also argued that social and role deficits are not merely consequences of increasing positive symptoms but represent enduring vulnerability traits evident in the early stages of illness.38 Furthermore, there are several other possible explanations for why social dysfunction during adolescence and emerging adulthood may pose a heightened risk for adverse outcomes. This developmental period is marked by critical tasks such as forming and maintaining interpersonal relationships. Consequently, the onset of social dysfunction during this time can be particularly disruptive, potentially undermining the successful navigation of these essential developmental milestones. Importantly, early interventions targeting social and role functioning in high-risk youth could mitigate these vulnerabilities, reduce the likelihood of long-term disability and possibly prevent later psychotic episodes.38
In summary, results of this current study underscore the continued significance of both social and role functioning, and a decline in social and role functioning, in predicting subsequent transition to psychosis in CHR participants in both short and long-term follow-up. Furthermore, these findings support the inclusion of the Global Functioning: Social and Role Scales in CHR assessment protocols and targeted psychosocial interventions.
Strengths and Limitations
Strengths of this study include examining the large sample of NAPLS 2 and NAPLS 3 combined as well as over 400 participants with longer-term follow up. There are limitations in this study. First, long-term outcomes could only be reported for 31% of the NAPLS 2 and 3 samples. To date, 452 individuals have been interviewed in the LTF study from NAPLS 2 and 3, with an additional 124 whose transition was confirmed in NAPLS 2 and 3 but not yet interviewed. Importantly, data from the 452 interviews indicated no differences in baseline age or education, or overall positive and negative symptoms. The interviewed group did, at baseline, have significantly better ratings on grandiosity and decreased ideational richness, however these differences were not clinically significant, and both were in the “questionably present” range. There were significant differences in baseline functioning with the interviewed group compared to those not interviewed having improved baseline social and role functioning. Again, these differences were not clinically significant in that differences were less than 1 point (i.e., differences of 0.19 and 0.27, respectively). It should be noted that the 2 groups did not differ in decline in social or role functioning. A notable observation was a higher number of females compared to males; possibly they were more willing to participate. Due to these differences in those interviewed versus those not interviewed and the number of participants who could not be interviewed, there is a high likelihood of non-random missingness.
However, to address the non-random missingness we repeated the Cox’s Hazard analysis with only the transitions that occurred during the original time frame of NAPLS 2 and 3 excluding the LTF participants. These findings were highly consistent with those from the full sample, suggesting that the original conclusions are robust.
Second, our transition rates are likely underestimated since we only found and interviewed 31% of the original sample.
Thirdly, since the purpose of the paper was to recognize the work of Dr. Cornblatt, we solely focused on the association of social and role functioning with transition to psychosis whereas other studies have explored additional predictive models.22,39 Several studies improved prediction by incorporating cognition, negative symptoms as well as functioning.37,40,41 For instance, the NAPLS calculator23 included a range of variables in addition to a decline in functioning prior to baseline. A large meta-analysis42 classified both functioning and APS as highly suggestive as risk factors for transition. Overall, most prediction models identified social functioning as a key predictor.23
Future Directions
Future research opportunities include investigation of the long-term trajectory (5+ years) of the functional deficits identified in youth at high-risk for psychosis available in the LTF study. Shorter term studies have confirmed the stability of functional deficits but the LTF longer-term follow-up will allow us to investigate subgroups with differing trajectories and outcomes as well as correlates of these outcomes.9 An examination of the correlates of functional outcome might shed some light onto factors that impact longer-term functional outcome that could possibly provide insight for interventions offered to high-risk individuals.
Conclusion
In conclusion, we want to further acknowledge the work of Dr. Barbara Cornblatt not only in her early genetic high-risk work but her insights in the emerging study of the psychosis prodrome. Her persistence in highlighting the core neurodevelopmental deficits manifesting as functional difficulties in adolescence, a key developmental period that shapes an individual’s life trajectory, will undoubtedly make a lasting impact on the early psychosis field.
Supplementary Material
Acknowledgments
We acknowledge the contributions of the late Dr. Barbara Cornblatt and Dr. Larry Seidman to the NAPLS consortium.
Contributor Information
Jean Addington, Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4Z6, Canada.
Monica Chu, Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4Z6, Canada.
Lu Liu, Department of Psychiatry, Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 4Z6, Canada.
Robert Heinssen, Independent Scholar, Garrett Park, MD 20896, United States.
Andrea Auther, Northwell, Glen Oaks, NY 11004, United States.
Carrie E Bearden, Departments of Psychiatry and Biobehavioral Sciences and Psychology, Semel Institute for Neuroscience and Human Behavior, UCLA, Los Angeles, CA 90095, United States.
Tyrone D Cannon, Department of Psychology, Yale University, New Haven, CT 06510, United States; Department of Psychiatry, Yale University, New Haven, CT 06519, United States.
Ricardo E Carrión, Northwell, Glen Oaks, NY 11004, United States.
Matcheri Keshevan, Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center and Massachusetts Mental Health Centre, Boston, MA 02115, United States.
Daniel H Mathalon, Department of Psychiatry, UCSF, and SFVA Medical Center, San Francisco, CA 94121, United States.
Thomas H McGlashan, Department of Psychiatry, Yale University, New Haven, CT 06519, United States.
Diana O Perkins, Department of Psychiatry, University of North Carolina, Chapel Hill, NC 27514, United States.
William S Stone, Department of Psychiatry, Harvard Medical School at Beth Israel Deaconess Medical Center and Massachusetts Mental Health Centre, Boston, MA 02115, United States.
Ming T Tsuang, Department of Psychiatry, UCSD, La Jolla, CA 92104, United States; Institute of Genomic Medicine, UCSD, La Jolla, CA 92093, United States.
Elaine F Walker, Departments of Psychology and Psychiatry, Emory University, Atlanta, GA 30322, United States.
Scott W Woods, Department of Psychiatry, Yale University, New Haven, CT 06519, United States.
Kristin S Cadenhead, Department of Psychiatry, UCSD, La Jolla, CA 92104, United States.
Funding
NAPLS 2 was supported by the National Institute of Mental Health (grant U01 MH081984 to J.A.; grants U01 MH081928, P50 MH080272, and Commonwealth of Massachusetts SCDMH82101008006 to Dr. Seidman; grants R01MH60720, U01MH082022, and K24 MH76191 to K.S.C.; grant U01 MH081902 to T.D.C.; P50 MH066286 (Prodromal Core), the Staglin Family Music Festival for Mental Health, the Shear Family Foundation and the Don S. Levin Trust to C.E.B.; grant U01 MH082004 to D.P.; grant U01 MH081988 to E.F.W.; grant U01 MH082022 to S.W.W.; and U01 MH081857-05 grant to Dr. Cornblatt). NAPLS 3 was supported by the National Institute of Mental Health (grant U01MH081984 to J.A.; grant U01MH081928 to W.S.S.; grant U01MH081944 to Dr. Cadenhead; grant U01MH081902 to T.D.C. and Bearden; grant U01MH082004 to D.O.P.; grant U01MH081988 to E.F.W.; grant U01MH082022 to S.W.W.; grant U01MH076989 to D.H.M.; grant UO1MH081857 to Dr. Cornblatt). NAPLS LTF was supported by the National Institute of Mental Health (grants R01MH123641, and U01MH081944 to K.S.C.; grant U01MH081984 to J.A.; grant U01MH081928 to W.S.S. and M.K.; grant U01MH081902 to T.D.C. and C.E.B.; grant U01MH082004 to DO.P.; grant U01MH081988 to E.F.W.; grant U01MH082022 to S.W.W.; grant U01MH076989 to D.H.M.; grant UO1MH081857 to Dr. Cornblatt).
Conflicts of Interest
None declared.
References
- 1. Harvey PD, Strassnig M. Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status. World Psychiatry. 2012;11:73-79. 10.1016/j.wpsyc.2012.05.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Reichenberg A, Feo C, Prestia D, Bowie CR, Patterson TL, Harvey PD. The course and correlates of everyday functioning in schizophrenia. Schizophr Res Cogn. 2014;1:e47-e52. 10.1016/j.scog.2014.03.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Addington J, Addington D. Patterns of premorbid functioning in first episode psychosis: relationship to 2-year outcome. Acta Psychiatr Scand. 2005;112:40-46. 10.1111/j.1600-0447.2005.00511.x [DOI] [PubMed] [Google Scholar]
- 4. Hafner H, Loffler W, Maurer K, Hambrecht M, W a d H. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand. 1999;100:105-118. 10.1111/j.1600-0447.1999.tb10831.x [DOI] [PubMed] [Google Scholar]
- 5. Cornblatt BA, Carrion RE, Addington J, et al. Risk factors for psychosis: impaired social and role functioning. Schizophr Bull. 2012;38:1247-1257. 10.1093/schbul/sbr136 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Addington J, Cadenhead KS, Cannon TD, et al. North American Prodrome longitudinal study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull. 2007;33:665-672. 10.1093/schbul/sbl075 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Addington J, Cadenhead KS, Cornblatt BA, et al. North American Prodrome longitudinal study (NAPLS 2): overview and recruitment. Schizophr Res. 2012;142:77-82. 10.1016/j.schres.2012.09.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Addington J, Liu L, Brummitt K, et al. North American Prodrome longitudinal study (NAPLS 3): methods and baseline description. Schizophr Res. 2022;243:262-267. 10.1016/j.schres.2020.04.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Cadenhead KS, Kennedy L, Mirzakhanian H, et al. Predictors and Moderators of Long-Term Outcome of Persons at Clinical High Risk for Psychosis: Methods and Preliminary Data. Schizophr Bull. in press. [DOI] [PMC free article] [PubMed]
- 10. Cornblatt BA, Auther AM, Niendam T, et al. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull. 2007;33:688-702. 10.1093/schbul/sbm029 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Auther A, Smith C, Cornblatt B. Global Functioning: Social Scale (GF: Social). Zucker-Hillside Hospital, 2006. [Google Scholar]
- 12. Niendam T, Bearden C, Johnson J, Cannon T. Global Functioning: Role Scale (GF: Role). Los Angeles, 2006. [Google Scholar]
- 13. Hall RC. Global assessment of functioning. A modified scale. Psychosomatics. 1995;36:267-275. 10.1016/S0033-3182(95)71666-8 [DOI] [PubMed] [Google Scholar]
- 14. Diagnostic and Statistical Manual of Mental Disorders 4th edn. American Psychiatric Association, 1994. [Google Scholar]
- 15. Carrion RE, Auther AM, McLaughlin D, et al. The global functioning: social and role scales-further validation in a large sample of adolescents and young adults at clinical high risk for psychosis. Schizophr Bull. 2019;45:763-772. 10.1093/schbul/sby126 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. PhenX Toolkit . Social and Role Dysfunction in Psychosis and Schizophrenia. 2025. https://www.phenxtoolkit.org/protocols/view/661201
- 17. Addington J, Cornblatt BA, Cadenhead KS, et al. At clinical high risk for psychosis: outcome for nonconverters. Am J Psychiatry. 2011;168:800-805. 10.1176/appi.ajp.2011.10081191 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Addington J, Stowkowy J, Liu L, et al. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis. Psychol Med. 2019;49:1670-1677. 10.1017/S0033291718002258 [DOI] [PubMed] [Google Scholar]
- 19. Addington J, Liu L, Chu M, et al. Baseline clinical characterization of participants in the accelerating medicines partnership® program. Schizophr Bull Open. 2025;6:sgaf012. 10.1093/schizbullopen/sgaf012. eCollection 2025 Jan. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Velthorst E, Zinberg J, Addington J, et al. Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis. Dev Psychopathol. 2018;30:39-47. 10.1017/S0954579417000451 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Carrion RE, Auther AM, McLaughlin D, et al. Social decline in the psychosis prodrome: predictor potential and heterogeneity of outcome. Schizophr Res. 2021;227:44-51. 10.1016/j.schres.2020.09.006 [DOI] [PubMed] [Google Scholar]
- 22. Addington J, Farris M, Devoe D, Metzak P. Progression from being at-risk to psychosis: next steps. NPJ Schizophr. 2020;6:27-27. 10.1038/s41537-020-00117-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Cannon TD, Yu C, Addington J, et al. An individualized risk calculator for research in prodromal psychosis. Am J Psychiatry. 2016;173:980-988. 10.1176/appi.ajp.2016.15070890 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Carrion RE, Cornblatt BA, Burton CZ, et al. Personalized prediction of psychosis: external validation of the NAPLS-2 psychosis risk calculator with the EDIPPP project. Am J Psychiatry. 2016;173:989-996. 10.1176/appi.ajp.2016.15121565 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. McGlashan TH, Walsh B, Woods S. The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-Up, Vol. xii. Oxford University Press, 2010. 243. [Google Scholar]
- 26. Williams M, Karg R, Spitzer R. Structured Clinical Interview for DSM-5–Research Version (SCID-5 for DSM-5, Research Version; SCID-5–RV). American Psychiatric Association, 2015. [Google Scholar]
- 27. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). American Psychiatric Press, 1997. [Google Scholar]
- 28. Addington J, Liu L, Braun A, et al. Sample ascertainment and clinical outcome measures in the accelerating medicines partnership(R) schizophrenia program. Schizophrenia (Heidelb). 2025;11:54. 10.1038/s41537-025-00556-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Lo Cascio N, Curto M, Pasqualetti P, et al. Impairment in social functioning differentiates youth meeting ultra-high risk for psychosis criteria from other mental health help-seekers: a validation of the Italian version of the global functioning: social and global functioning: role scales. Psychiatry Res. 2017;253:296-302. 10.1016/j.psychres.2017.04.008 [DOI] [PubMed] [Google Scholar]
- 30. Lucarini V, Kazes M, Krebs E, et al. Validation of the French version of the global functioning: social and global functioning: role scales in adolescents and young adults seeking help in early intervention clinics. Early Interv Psychiatry. 2024;18:3-9. 10.1111/eip.13427 [DOI] [PubMed] [Google Scholar]
- 31. Early Psychosis Intervention Network . (2022). Core Assessment Battery (CAB). https://nationalepinet.org/core-assessment-battery-cab/
- 32. Heinssen RK, Azrin ST. A National Learning Health Experiment in early psychosis research and care. Psychiatr Serv. 2022;73:962-964. 10.1176/appi.ps.20220153 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Brucato G, Masucci MD, Arndt LY, et al. Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort. Psychol Med. 2017;47:1923-1935. 10.1017/S0033291717000319 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Corcoran CM, Kimhy D, Parrilla-Escobar MA, et al. The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis. Psychol Med. 2011;41:251-261. 10.1017/S0033291710000802 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Demjaha A, Valmaggia L, Stahl D, Byrne M, McGuire P. Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis. Schizophr Bull. 2012;38:351-359. 10.1093/schbul/sbq088 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Healey, Penn DL, Perkins D, Woods SW, Keefe RSE, Addington J. Latent profile analysis and conversion to psychosis: characterizing subgroups to enhance risk prediction. Schizophr Bull. 2018;44:286-296. 10.1093/schbul/sbx080 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Cornblatt BA, Carrion RE, Auther A, et al. Psychosis prevention: a modified clinical high risk perspective from the recognition and prevention (RAP) program. Am J Psychiatry. 2015;172:986-994. 10.1176/appi.ajp.2015.13121686 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Cornblatt BA, Lencz T, Smith CW, Correll CU, Auther AM, Nakayama E. The schizophrenia prodrome revisited: a neurodevelopmental perspective. Schizophr Bull. 2003;29:633-651. 10.1093/oxfordjournals.schbul.a007036 [DOI] [PubMed] [Google Scholar]
- 39. Studerus E, Ramyead A, Riecher-Rossler A. Prediction of transition to psychosis in patients with a clinical high risk for psychosis: a systematic review of methodology and reporting. Psychol Med. 2017;47:1163-1178. 10.1017/S0033291716003494 [DOI] [PubMed] [Google Scholar]
- 40. Hengartner MP, Heekeren K, Dvorsky D, Walitza S, Rossler W, Theodoridou A. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: results of a longitudinal observation study over three years focusing on both converters and non-converters. Schizophr Res. 2017;189:19-26. 10.1016/j.schres.2017.01.040 [DOI] [PubMed] [Google Scholar]
- 41. Addington J, Liu L, Perkins DO, Carrion RE, Keefe RS, Woods SW. The role of cognition and social functioning as predictors in the transition to psychosis for youth with attenuated psychotic symptoms. Schizophr Bull. 2017;43:57-63. 10.1093/schbul/sbw152 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Oliver D, Reilly TJ, Baccaredda Boy O, et al. What causes the onset of psychosis in individuals at clinical high risk? A meta-analysis of risk and protective factors. Schizophr Bull. 2020;46:110-120. 10.1093/schbul/sbz039 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.

